相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types
R. W. D. Welford et al.
HUMAN MOLECULAR GENETICS (2018)
Na(V)1.7 as a Pharmacogenomic Target for Pain: Moving Toward Precision Medicine
Yang Yang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Signatures of Altered Gene Expression in Dorsal Root Ganglia of a Fabry Disease Mouse Model
Kai K. Kummer et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
A TRP channel trio mediates acute noxious heat sensing
Ine Vandewauw et al.
NATURE (2018)
Lucerastat, an Iminosugar for Substrate Reduction Therapy: Tolerability, Pharmacodynamics, and Pharmacokinetics in Patients With Fabry Disease on Enzyme Replacement
Nicolas Guerard et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Neuropathic pain in a Fabry disease rat model
James J. Miller et al.
JCI INSIGHT (2018)
Protein kinase A regulates inflammatory pain sensitization by modulating HCN2 channel activity in nociceptive sensory neurons
Stefan Herrmann et al.
PAIN (2017)
Hyperpolarization-activated cyclic nucleotide-gated 2 (HCN2) ion channels drive pain in mouse models of diabetic neuropathy
Christoforos Tsantoulas et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Changes in Ionic Conductance Signature of Nociceptive Neurons Underlying Fabry Disease Phenotype
Barbara Namer et al.
FRONTIERS IN NEUROLOGY (2017)
TRPA1 and TRPV1 are required for lidocaine-evoked calcium influx and neuropeptide release but not cytotoxicity in mouse sensory neurons
Mirjam Eberhardt et al.
PLOS ONE (2017)
Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice
Lawrence M. Carey et al.
SCIENTIFIC REPORTS (2017)
Gangliosides of the Vertebrate Nervous System
Ronald L. Schnaar
JOURNAL OF MOLECULAR BIOLOGY (2016)
How Membrane Dysfunction Influences Neuronal Survival Pathways in Sphingolipid Storage Disorders
Tuba Sural-Fehr et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2016)
Comprehensive and differential long-term characterization of the alpha-galactosidase A deficient mouse model of Fabry disease focusing on the sensory system and pain development
Nurcan Ueceyler et al.
MOLECULAR PAIN (2016)
Increased expression of Trpv1 in peripheral terminals mediates thermal nociception in Fabry disease mouse model
Jarmila Lakoma et al.
MOLECULAR PAIN (2016)
Increased oxidative stress contributes to cardiomyocyte dysfunction and death in patients with Fabry disease cardiomyopathy
Cristina Chimenti et al.
HUMAN PATHOLOGY (2015)
Characteristics of hyperpolarization-activated cyclic nucleotide-gated channels in dorsal root ganglion neurons at different ages and sizes
Baohua Hou et al.
NEUROREPORT (2015)
The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain
L. Choi et al.
NEUROSCIENCE LETTERS (2015)
Characterization of Pain in Fabry Disease
Nurcan Ueceyler et al.
CLINICAL JOURNAL OF PAIN (2014)
Dynamic-clamp analysis of wild-type human Nav1.7 and erythromelalgia mutant channel L858H
Dmytro V. Vasylyev et al.
JOURNAL OF NEUROPHYSIOLOGY (2014)
Sodium channel genes in pain-related disorders: phenotype-genotype associations and recommendations for clinical use
Stephen G. Waxman et al.
LANCET NEUROLOGY (2014)
Sphingosine 1-phosphate to p38 signaling via S1P1 receptor and Gαi/o evokes augmentation of capsaicin-induced ionic currents in mouse sensory neurons
Michiel Langeslag et al.
MOLECULAR PAIN (2014)
HCN2 channels account for mechanical (but not heat) hyperalgesia during long-standing inflammation
Sabine Schnorr et al.
PAIN (2014)
Pain Related Channels Are Differentially Expressed in Neuronal and Non-Neuronal Cells of Glabrous Skin of Fabry Knockout Male Mice
Jarmila Lakoma et al.
PLOS ONE (2014)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
HCN2 ion channels: an emerging role as the pacemakers of pain
Edward C. Emery et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Globotriaosylceramide leads to KCa3.1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease
Seonghee Park et al.
CARDIOVASCULAR RESEARCH (2011)
Small fibers in Fabry disease: baseline and follow-up data under enzyme replacement therapy
Nurcan Ueceyler et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2011)
Higher apoptotic state in Fabry disease peripheral blood mononuclear cells. Effect of globotriaosylceramide
Pablo N. De Francesco et al.
MOLECULAR GENETICS AND METABOLISM (2011)
HCN2 Ion Channels Play a Central Role in Inflammatory and Neuropathic Pain
Edward C. Emery et al.
SCIENCE (2011)
Substrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry Disease
John Marshall et al.
PLOS ONE (2010)
Role of the Unfolded Protein Response Regulator GRP78/BiP in Development, Cancer, and Neurological Disorders
Miao Wang et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice
L. G. Rodrigues et al.
NEUROBIOLOGY OF DISEASE (2009)
Hyperpolarization-Activated Cation Channels: From Genes to Function
Martin Biel et al.
PHYSIOLOGICAL REVIEWS (2009)
Lysosomal storage disease 3 - Fabry's disease
Yuri A. Zarate et al.
LANCET (2008)
Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells
Jin-Song Shen et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Detection of a Characteristic Painful Neuropathy in Fabry Disease: A Pilot Study
Rainer Maag et al.
PAIN MEDICINE (2008)
EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy
G Lauria et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress
AS Lee
METHODS (2005)
Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain
MA Nassar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Neuronal hyperpolarization-activated pacemaker channels drive neuropathic pain
SR Chaplan et al.
JOURNAL OF NEUROSCIENCE (2003)
Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease.
CM Eng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
A Hartmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
